Targeting AMP-activated protein kinase in sepsis

被引:0
|
作者
Yumoto, Tetsuya [1 ,2 ,3 ]
Coopersmith, Craig M. [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30307 USA
[2] Emory Univ, Emory Crit Care Ctr, Sch Med, Atlanta, GA 30307 USA
[3] Okayama Univ, Fac Med, Dept Emergency Crit Care & Disaster Med, Okayama, Japan
来源
基金
美国国家卫生研究院;
关键词
AMP activated kinase; metformin; AICAR; sepsis; treatment; MACROPHAGE POLARIZATION; HMGB1; RELEASE; ORGAN INJURY; LIVER-INJURY; METFORMIN; PATHWAY; AUTOPHAGY; SURVIVAL; INFLAMMATION; ENDOTOXEMIA;
D O I
10.3389/fendo.2024.1452993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a global health challenge marked by limited clinical options and high mortality rates. AMP-activated protein kinase (AMPK) is a cellular energy sensor that mediates multiple crucial metabolic pathways that may be an attractive therapeutic target in sepsis. Pre-clinical experimental studies have demonstrated that pharmacological activation of AMPK can offer multiple potential benefits during sepsis, including anti-inflammatory effects, induction of autophagy, promotion of mitochondrial biogenesis, enhanced phagocytosis, antimicrobial properties, and regulation of tight junction assembly. This review aims to discuss the existing evidence supporting the therapeutic potential of AMPK activation in sepsis management.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Is creatine kinase a target for AMP-activated protein kinase in the heart?
    Ingwall, JS
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (09) : 1111 - 1120
  • [32] Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase
    Beyer, A
    Kitzerow, A
    Crute, B
    Kemp, BE
    Witters, LA
    Heilmeryer, LMG
    BIOLOGICAL CHEMISTRY, 2000, 381 (5-6) : 457 - 461
  • [33] Targeting of AMP-activated protein kinase: prospects for computer-aided drug design
    Kim, Joungmok
    Yang, Goowon
    Ha, Joohun
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (01) : 47 - 59
  • [34] Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes
    Eric B. Taylor
    Laurie J. Goodyear
    Current Diabetes Reports, 2007, 7 (6) : 399 - 401
  • [35] Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders
    Viollet, B.
    Mounier, R.
    Leclerc, J.
    Yazigi, A.
    Foretz, M.
    Andreelli, F.
    DIABETES & METABOLISM, 2007, 33 (06) : 395 - 402
  • [36] The regulation of AMP-activated protein kinase by upstream kinases
    Carling, D.
    Sanders, M. J.
    Woods, A.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 4) : S55 - S59
  • [37] AMP-activated protein kinase and hypoxic pulmonary vasoconstriction
    Robertson, Tom P.
    Mustard, Kirsteen J. W.
    Lewis, Tristan H.
    Clark, Jill H.
    Wyatt, Christopher N.
    Blanco, Elisa A.
    Peers, Chris
    Hardie, D. Grahame
    Evans, A. Mark
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 595 (1-3) : 39 - 43
  • [38] AMP-activated protein kinase: An emerging target for ginseng
    Jeong, Kyong Ju
    Kim, Go Woon
    Chung, Sung Hyun
    JOURNAL OF GINSENG RESEARCH, 2014, 38 (02) : 83 - 88
  • [39] The regulation of AMP-activated protein kinase by upstream kinases
    D Carling
    M J Sanders
    A Woods
    International Journal of Obesity, 2008, 32 : S55 - S59
  • [40] Sanguinarine is an allosteric activator of AMP-activated protein kinase
    Choi, Jiwon
    He, Ningning
    Sung, Mi-Kyung
    Yang, Young
    Yoon, Sukjoon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (02) : 259 - 263